StocksMedium•12 November 2026•
1 min read
Mangoceuticals to Issue First Nasdaq-Listed Tokenized Preferred Stock via T7X Partnership
Key Facts
1Mangoceuticals announced a partnership with T7X to issue Series D Preferred Stock as tokens natively on-chain.
2The preferred stock will be offered at $10.00 per share, with no common stock issued at closing.
Mangoceuticals announced a partnership with T7X to issue Series D Preferred Stock as tokens natively on-chain. GlobeNewswire reported that the preferred stock will be offered at $10.00 per share, and the company confirmed that no common stock will be issued at the closing of the transaction.
Mangoceuticals is the first Nasdaq-listed company to issue a security on the T7X platform, aiming to leverage digital asset infrastructure for capital raising and wellness brand expansion. MGRX closed at $0.1993 on November 11, 2026, after reaching a session high of $0.20495.